悪性胸膜中皮腫における新規バイオマーカーとしての循環腫瘍細胞の意義
森將鷹, 眞鍋尭彦, 根本有希子, 小山倫太郎, 西澤夏將, 本多陽平, 松宮弘喜, 金山雅俊, 竹中賢, 田嶋裕子, 黒田耕志, 田中文啓
JOURNAL OF UOEH, 2024, Reviewed, No invitation
特発性血気胸に対する胸腔鏡下手術14例の検討
金山 雅俊, 大崎 敏弘, 西澤 夏將, 中川 誠, 宗 知子, 小舘 満太郎
日本呼吸器外科学会雑誌, Nov. 2016, Null, Null
肺切除を施行した膵癌術後肺転移の3例
金山 雅俊, 大崎 敏弘, 西澤 夏將, 中川 誠, 小舘 満太郎, 梶山 潔
日本臨床外科学会雑誌, May 2016, Null, Null
胸腺原発大細胞神経内分泌癌の1例
西澤 夏將, 大崎 敏弘, 金山 雅俊, 中川 誠, 宗 知子, 小館 満太郎
肺癌, Dec. 2015, Null, Null
Lead
Postoperative cerebral infarction risk is related to lobectomy site in lung cancer: a retrospective cohort study of nationwide data in Japan.
Nishizawa Natsumasa, Okawara Makoto, Mori Masataka, Fujino Yoshihisa, Matsuda Shinya, Fushimi Kiyohide, Tanaka Fumihiro
BMJ open respiratory research, Jul. 2022, Reviewed, No invitation
Lead, Corresponding
Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
Kanayama Masatoshi, Kuwata Taiji, Mori Masataka, Nemoto Yukiko, Nishizawa Natsumasa, Oyama Rintaro, Matsumiya Hiroki, Taira Akihiro, Shinohara Shinji, Takenaka Masaru, Yoneda Kazue, Kuroda Koji, Ohnaga Takashi, Tanaka Fumihiro
Cancer science, Mar. 2022, Null, Null
A case of salvage surgery following chemoradiotherapy and durvalumab for initially unresectable superior sulcus tumor with N3 involvement.
Manabe Takehiko, Kanayama Masatoshi, Matsumiya Hiroki, Yoshimatsu Katsuma, Mori Masataka, Nishizawa Natsumasa, Taira Akihiro, Takenaka Masaru, Kuroda Koji, Azuma Koichi, Tanaka Fumihiro
General thoracic and cardiovascular surgery cases, Oct. 2024, Reviewed, Null
Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy.
Mori Masataka, Kanayama Masatoshi, Kuwata Taiji, Manabe Takehiko, Nemoto Yukiko, Nishizawa Natsumasa, Oyama Rintaro, Matsumiya Hiroki, Nabe Yusuke, Taira Akihiro, Takenaka Masaru, Yoneda Kazue, Kuroda Koji, Tanaka Fumihiro
Scientific reports, Feb. 2023, Reviewed, Null
Prognostic factors of resected pathological stage I lung adenocarcinoma: evaluating subtypes and PD-L1/CD155 expression.
Nishizawa Natsumasa, Shimajiri Shohei, Oyama Rintaro, Manabe Takehiko, Nemoto Yukiko, Matsumiya Hiroki, Honda Yohei, Taira Akihiro, Takenaka Masaru, Kuroda Koji, Tanaka Fumihiro
Scientific reports, Dec. 2023, Reviewed, Null
Lead
